FindDrugs.org

Gala Health Weight Loss / GLP-1 Review

Weight Loss / GLP-1 · Reviewed Sep 23, 2026

5.93/10
Gala Health operator trust5.67/10See the full Gala Health brand review
Cash-pay

Our verdict

Gala publishes the two things this category most often hides — a price before signup and the criteria it screens against — and hides the one most brands now publish, which is who fills the prescription. Compounded GLP-1/GIP is advertised at $179 a month on a yearly plan, branded Ozempic at $1,299, and the eligibility page states a BMI of 27 with a weight-related condition or 30 without. Against that, no compounding pharmacy is named anywhere, no clinician is named, and the homepage shows three medical-school logos under a line claiming where its doctors trained and practised with nothing published to check them against.

Price

from $179/mo · 3 plans

Visit Gala Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • Compounded GLP-1/GIP advertised at $179/month on a yearly plan; the FAQ quotes $199/month on a three-month plan
  • Branded Ozempic offered at $1,299/month; a Wegovy pill is listed as coming soon
  • BMI ≥ 27 with a weight-related condition, or ≥ 30 without, published before signup — the FDA-labelled indication
  • Labelled contraindications published on both drug pages: medullary thyroid cancer, MEN 2, pancreatitis
  • No compounding pharmacy named and no 503A/503B status published
  • No clinician named; the homepage shows Harvard, Columbia and Mount Sinai logos under a line claiming where its doctors trained and practised
  • Billing starts at intake; cancel at least 72 hours before the billing date or the next cycle is charged
  • No refund on cancellation except where Gala's provider disqualifies the patient

What is Gala Health Weight Loss / GLP-1?

Gala GLP-1 is the weight-loss line of AI Coaching Inc., a Delaware-registered company selling cash-pay telehealth in three categories: GLP-1 weight loss, menopause hormone therapy and two longevity peptides. Gala says it provides administrative, technology and management services and does not provide medical care; prescribing is done by clinicians affiliated with independently owned practices, including OpenLoop-affiliated medical groups. It says it operates in all 50 states.

Treatment options

Prices as of Sep 23, 2026 — verify current on the brand's site.

Getting started with Gala Health

  1. Complete the online health assessment — Gala says about five minutes
  2. A state-licensed provider reviews the intake; a video visit may be required depending on state and medication
  3. If prescribed, medication ships from a pharmacy Gala does not name
  4. Dose changes and kit switches run through in-app provider messaging at no extra charge

Methodology scorecard

Scored on Sep 23, 2026 under methodology v6

5.93/10
  • Legitimacy & Accreditation
    Critical

    Evidence (as scored Sep 23, 2026): The operating entity is named in the terms of service and the site footer as AI Coaching Inc., d/b/a Gala GLP-1, at a Wilmington, Delaware address, with a support email. No third-party accreditation is claimed anywhere on the site — there is no LegitScript, NABP or pharmacy-accreditation badge — and none was verified. The FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB has no profile under any spelling we tried. — galaglp1.com, Sep 22, 2026

  • Clinical Oversight & Safety
    Critical

    Evidence (as scored Sep 23, 2026): Gala says a state-licensed provider reviews every intake and that medication is prescribed only where a provider judges it appropriate. It states that medical services are delivered by clinicians affiliated with independently owned practices including OpenLoop-affiliated medical groups, and that Gala itself provides administrative, technology and management services and does not provide medical care. No individual clinician is named anywhere on the site. — galaglp1.com, Sep 22, 2026

  • Sourcing Transparency & Legal Context
    High

    Evidence (as scored Sep 23, 2026): We work with a wide network of pharmacies across all 50 states. — FDA drug information — Compounding And FDA Questions And Answers, Sep 16, 2025

  • Data Privacy & Security
    Medium

    Evidence (as scored Sep 23, 2026): A privacy policy is published and the homepage displays a “HIPAA Compliant” badge. The badge is a claim by Gala and is not a certification we can check — HIPAA has no certifying body — so it is recorded as displayed, not as verified. — galaglp1.com, Sep 22, 2026

  • Pricing Transparency & Value
    Critical

    Evidence (as scored Sep 23, 2026): In stock Compounded GLP-1/GIP incl. tirzepatide $179/month* ... In stock Ozempic® Brand-name semaglutide $1,299/month — galaglp1.com, Sep 22, 2026

  • Policy Clarity & Fairness
    High

    Evidence (as scored Sep 23, 2026): The cancellation and refund terms are published in full and are specific. Gala says billing starts when the intake form is completed; that a cancellation request must arrive at least 72 hours before the billing date or the next cycle is charged; that a patient disqualified by its provider receives a full refund; and, in capitals, that in no other event is a refund issued on cancellation. Refunds, where allowed, are limited to the most recent billing cycle. — galaglp1.com, Sep 22, 2026

  • Popularity & Momentum
    Medium

    Evidence (as scored Sep 23, 2026): Gala says it has more than 50,000 patients and its pages carry a Trustpilot mark. We could not verify either figure: trustpilot.com returned HTTP 403 to automated retrieval, and the review counters on Gala's own pages render as zero without client-side scripting, so no rating or volume was readable. The claim is recorded as Gala's and the limit is in gaps. — galaglp1.com, Sep 22, 2026

  • Quality-under-Growth
    Medium

    Evidence (as scored Sep 23, 2026): Nothing adverse is on any public record we could reach: the FDA enforcement register returns no entry for Gala or AI Coaching, and the BBB returns no business profile. Both searches were run with a positive control that discriminates — the same FDA query shape returns entries for MEDVi and Lean Rx. No complaint corpus was reachable, so this records an absence of findings on the registers we can read, not an absence of complaints. — FDA warning-letter register — search for "gala", Sep 22, 2026

  • Access & Speed
    Medium

    Evidence (as scored Sep 23, 2026): Gala publishes its own timings: a five-minute intake for weight loss and a five-to-seven-minute intake for the longevity compounds, an asynchronous provider review with no video call required for longevity, and up to a three-month supply per longevity visit. It says consultations may be synchronous or asynchronous depending on the patient, the state and the medication, and that any video visit is typically only the first session. — galaglp1.com, Sep 22, 2026

  • Transparency & Disclosure
    Critical

    Evidence (as scored Sep 23, 2026): Two things are disclosed well and two are not. Gala labels compounded GLP-1 as not FDA-approved repeatedly and prominently, including in its own pricing footnote and throughout its FAQ, and it publishes BMI thresholds and the labelled contraindications on the drug pages. Against that: it names no compounding pharmacy, saying only that it works with “a wide network of pharmacies across all 50 states”; it names no individual clinician; and its homepage displays the logos of Harvard Medical School, Columbia University Medical Center and Mount Sinai under a line claiming where its doctors trained and practised, with no clinician named and nothing published to check the affiliation against. — FDA drug information — Compounding And FDA Questions And Answers, Sep 16, 2025

  • Support & Care Model
    Supporting

    Evidence (as scored Sep 23, 2026): Gala says provider messaging, dose adjustments and switching between medication kits are included at no extra cost, and that a higher dose carries no additional charge. It advertises 24/7 access to asynchronous provider messaging. — galaglp1.com, Sep 22, 2026

  • Titration Autonomy
    High

    Evidence (as scored Sep 23, 2026): — dailymed.nlm.nih.gov, Sep 21, 2026

  • Weight-Management Care Model
    Medium

    Evidence (as scored Sep 23, 2026): Depending on the patient, state laws, or type of medication, consultations may be synchronous—such as a video visit—or asynchronous, like online messaging. — galaglp1.com, Sep 22, 2026

  • Eligibility Screening
    High

    Evidence (as scored Sep 23, 2026): Have a BMI ≥ 27 with weight-related conditions, or ≥ 30 regardless of comorbidities — dailymed.nlm.nih.gov, Sep 21, 2026

Pricing & cancellation

Visit Gala Health

All-in price

from $179/mo · 3 options

Cost structure
Subscription. GLP-1 advertised at $179/month on a yearly plan and $199/month on a three-month plan; longevity at $199/month for 28 days or $118/month on a 12-month plan; HRT from $69/month.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Cancel any time, but the request must arrive at least 72 hours before the billing date or the next cycle is charged. Billing starts when the intake form is completed.
Forced subscription
Required

Pros & cons

Pros

  • A headline price is published before signup on all three lines, which most of this category does not do
  • GLP-1 eligibility is published before signup at the FDA-labelled thresholds — BMI ≥ 27 with a weight-related condition, or ≥ 30 without
  • Labelled contraindications are published on both GLP-1 drug pages
  • Compounded GLP-1 is labelled not FDA-approved in Gala's own pricing footnote and throughout its FAQ
  • The longevity pages state in Gala's own words that there is no clinical trial for the compound bundle to cite
  • Four HRT routes are offered, including a published non-hormonal path
  • Gala says dose changes, kit switches and provider messaging carry no extra charge

Cons

  • No compounding pharmacy is named on any line, and no 503A or 503B classification is published
  • No individual clinician is named anywhere on the site
  • The homepage displays Harvard, Columbia and Mount Sinai logos under a claim about where its doctors trained, with nothing published to check it against
  • The HRT pages publish four outcome percentages with no source attached
  • The HRT pages never state which regulatory category the hormones fall into — an approved product, or a compounded preparation, though the GLP-1 line is labelled
  • Sermorelin lists elevated IGF-1 as an exclusion but describes no bloodwork that would detect it
  • Billing starts at intake, cancellation requires 72 hours' notice, and outside medical disqualification the published policy is that no refund is issued
  • Two different entry prices are advertised for GLP-1 — $179/month on the homepage and $199/month in the FAQ — on different commitments

Safety

Talk to a licensed clinician

Both GLP-1 drug pages publish the labelled semaglutide and tirzepatide contraindications: medullary thyroid cancer, multiple endocrine neoplasia type 2 and pancreatitis. Gala describes the common side effects as nausea, upset stomach and digestive discomfort, says they often improve over time, and tells patients to contact a provider if symptoms are severe or persistent. The site does not reproduce the boxed warning that appears on the approved labels for these drugs.

Common side effects

  • Nausea
  • Upset stomach
  • Digestive discomfort
  • Diarrhoea

Who should not take it

  • Medullary thyroid cancer
  • Multiple endocrine neoplasia type 2
  • Pancreatitis

The bottom line

A reasonable choice if a published price and published screening criteria matter more to you than knowing who compounds your medication. The 72-hour cancellation window and the no-refund-on-cancellation rule are worth reading before the first charge, because billing begins at intake.

Visit Gala Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

See how Gala Health ranks among GLP-1 providers

Frequently asked questions

How much does Gala GLP-1 cost?

Gala advertises compounded GLP-1/GIP at $179 a month, footnoted as a yearly subscription, and branded Ozempic at $1,299 a month. Its FAQ separately says treatment starts at $199 a month on a three-month plan. Final pricing is stated to be set at checkout.

Which pharmacy fills the prescription?

Gala does not say. It states that it works with a wide network of pharmacies across all 50 states and that ingredients come from FDA-regulated suppliers, but no pharmacy is named and no 503A or 503B classification is published.

Is the medication FDA-approved?

The branded Ozempic is. The compounded GLP-1/GIP line is not, and Gala says so itself in its pricing footnote and through its FAQ. Compounded drugs are not reviewed or approved by the FDA.

Can I cancel?

Yes, at any time, but the request must reach Gala at least 72 hours before the billing date or the next cycle is charged. Except where Gala's provider disqualifies you, the published policy is that no refund is issued on cancellation.

Work at Gala Health?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 14 of 14 factors · 11 sources cited

Regulatory

Other

What we couldn't verify

  • Gala names no pharmacy on any of its three lines, saying only that it works with “a wide network of pharmacies across all 50 states” and that ingredients come from FDA-regulated suppliers. No licence number and no 503A or 503B classification appears anywhere on the site. This is an absence on Gala's own pages, confirmed across the homepage, the About FAQ and every product page, not a retrieval failure.
  • Gala says it has more than 50,000 patients and its pages carry a Trustpilot mark. trustpilot.com returned HTTP 403 to automated retrieval on 2026-09-22, and trustpilot.com is recorded `refused` on terms, so no rendered fetch is available either; solving or routing around the block is not a retrieval method this project uses. The counters on Gala's own pages render as zero without client-side scripting, so no rating or volume was readable there. FindDrugs therefore holds no sentiment figure it retrieved itself and publishes none. THIS IS NOT A FINDING THAT THE CLAIM IS FALSE.
  • The federal-docket check ran on 2026-09-21 against the CourtListener REST API v4 (the only sanctioned route — courtlistener.com is refused on terms), with the positive control “Mochi Health” returning 15 records, so the search works. All three queries — “AI Coaching Inc”, “Gala GLP-1” and “Gala Health” — returned records whose case captions contain none of those strings: the matches are case body text about unrelated matters, because the names match ordinary English words. That is TOO GENERIC TO BE EVIDENCE and supports no claim in either direction. There is no measured absence here, and nothing on any Gala page says there is.
  • Gala's homepage displays the three institutions' logos under a line claiming where its doctors trained and practised. No clinician is named anywhere on the site, and nothing is published that would let the affiliation be checked — no name, no credential, no institution-side listing. The claim is recorded as one Gala makes and is not repeated as established anywhere in this review.
  • The page publishes hot flashes resolved at eight weeks, sleep improvement, mood and anxiety relief and bone-loss reduction as percentages, with no source attached to any of them. FindDrugs holds no record for these figures and does not repeat them as findings; they are reported as claims Gala makes.
  • Gala labels its GLP-1 line as not FDA-approved repeatedly and prominently, but the hormone pages carry no equivalent statement. They describe the products as “bioidentical”, which is a marketing term covering both FDA-approved products and compounded preparations, so the question is unresolved on Gala's own pages.
  • Gala's sermorelin page lists elevated prolactin or IGF-1 among the conditions that make the peptide inappropriate, but nothing on the page describes a baseline IGF-1 draw or any bloodwork, and the stated follow-up is a quarterly asynchronous questionnaire. Whether a test happens inside the intake is not published.
  • Gala says licensed providers in all 50 states across each of its three lines. That statement was not verified against state licence records; no such record was retrieved for this review.
Last reviewed Sep 23, 2026 · methodology v6View the ledger

Top pick

Gala Health 5.93/10